My suspicion is that this acquisition will lead to the relaunch of the left product. I strongly dislike the capital raise a these levels - who would've thought?
But with 3-digit annual growth (FY23), CF+, EBITDA+, ex-CEO's gone, one would think that the SP will significantly rerate in the coming months?
My suspicion is that this acquisition will lead to the relaunch...
Add HLF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.805M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| HLF (ASX) Chart |
Day chart unavailable